Drug Shortage Report for TARO-GLICLAZIDE MR
Report ID | 107082 |
Drug Identification Number | 02439328 |
Brand name | RAN-GLICLAZIDE MR |
Common or Proper name | GLICLAZIDE MR |
Company Name | SUN PHARMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | GLICLAZIDE |
Strength(s) | 60MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A10BB |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-02-21 |
Estimated end date | 2020-07-03 |
Actual end date | 2020-08-18 |
Shortage status | Resolved |
Updated date | 2020-08-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2020-08-28 | French | Compare |
v13 | 2020-08-28 | English | Compare |
v12 | 2020-06-01 | French | Compare |
v11 | 2020-06-01 | English | Compare |
v10 | 2020-05-07 | French | Compare |
v9 | 2020-05-07 | English | Compare |
v8 | 2020-04-20 | French | Compare |
v7 | 2020-04-20 | English | Compare |
v6 | 2020-04-03 | French | Compare |
v5 | 2020-04-03 | English | Compare |
v4 | 2020-03-07 | French | Compare |
v3 | 2020-03-07 | English | Compare |
v2 | 2020-02-24 | French | Compare |
v1 | 2020-02-24 | English | Compare |
Showing 1 to 14 of 14